Hpr6 (Heme-1 Domain Protein) Regulates the Susceptibility of Cancer Cells to Chemotherapeutic Drugs

2005/12/21 by Gerard Crudden, Rachel E. Chitti, Rolf J. Craven · 16 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Biochemistry #Biology #Cancer #Cancer cell #Cancer research #Cancer, Hypoxia, and Metabolism #Chemistry #Chemotherapeutic drugs #Domain (mathematical analysis) #Endoplasmic Reticulum Stress and Disease #Enzyme #Genetics #Heme #Pancreatic function and diabetes #Pharmacology

paper · doi:10.1124/jpet.105.094631

openalex publication_date 2005/12/21 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• PGRMC1 (progesterone receptor membrane component 1): A targetable protein with multiple functions in steroid signaling, P450 activation and drug binding
• Neurosteroid regulation of central nervous system development. [europepmc]
• PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. [europepmc]
• Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics. [europepmc]
• Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression. [europepmc]
• Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. [europepmc]
• Evidence for a genomic mechanism of action for progesterone receptor membrane component-1. [europepmc]
• Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands. [europepmc]
• Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors. [europepmc]
• PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival. [europepmc]
• Pgrmc1 Knockout Impairs Oocyte Maturation in Zebrafish. [europepmc]
• Downregulation of CYB5D2 is associated with breast cancer progression. [europepmc]
• NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines. [europepmc]
• Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells. [europepmc]
• Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma. [europepmc]
• Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity. [europepmc]